MaxLinear
209 hedge funds and large institutions have $1.41B invested in MaxLinear in 2024 Q4 according to their latest regulatory filings, with 37 funds opening new positions, 73 increasing their positions, 69 reducing their positions, and 34 closing their positions.
39% more capital invested
Capital invested by funds: $1.01B → $1.41B (+$398M)
1% more funds holding
Funds holding: 206 → 209 (+3)
1.17% more ownership
Funds ownership: 83.25% → 84.42% (+1.2%)
9% more first-time investments, than exits
New positions opened: 37 | Existing positions closed: 34
6% more call options, than puts
Call options by funds: $10M | Put options by funds: $9.48M
6% more repeat investments, than reductions
Existing positions increased: 73 | Existing positions reduced: 69
Top Buyers
| 1 |
Manulife (Manufacturers Life Insurance)
Canada,
Ontario, Canada
|
+$23.8M |
| 2 |
PHK
Point72 Hong Kong
Hong Kong
|
+$20.8M |
| 3 |
SSA
Schonfeld Strategic Advisors
New York
|
+$20.3M |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
+$19.1M |
| 5 |
Morgan Stanley
New York
|
+$17.8M |
Top Sellers
MXL Hedge Fund Activity: Q4 2024 in Review
209 of the 7,592 institutional investors tracked by Wall St. Rank reported a position in MaxLinear (MXL) for Q4 2024, worth a combined $1.41B — up 39% from $1.01B a quarter earlier.
Buyers outnumbered sellers: 37 funds opened new MXL positions and 34 closed out — a net gain of 3 holders — while 73 added to existing stakes and 69 trimmed.
The largest buyer was Manulife (Manufacturers Life Insurance), adding an estimated $23.8M. The largest seller was Invesco, cutting an estimated $91.9M.
- 209 institutional investors held MaxLinear (MXL) as of Q4 2024, up from 206 in Q3 2024.
- Funds reported $1.41B of MaxLinear stock for Q4 2024, up 39% quarter-over-quarter.
- 37 funds opened new MaxLinear positions in Q4 2024 and 34 closed out, a net change of +3 holders.
- The largest MaxLinear buyer in Q4 2024 was Manulife (Manufacturers Life Insurance), an estimated $23.8M added.
- The largest MaxLinear seller in Q4 2024 was Invesco, an estimated $91.9M sold.
Based on aggregated 13F filings for Q4 2024.